Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

NCT00335270 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00335270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
December 31, 2007
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv